Search results for: 'c2 fall comput'

The discovery of new drug targets for diseases with unmet medical needs has long been hindered by the complexity of processing and interpreting massive volumes of biological data. The increasing volume and veracity of clinical and research data compels the use of enabling tools and technologies, such as cloud computing, AI, machine learning, natura...

The 2025 US Automotive Technicians’ Choice study is an insightful voice-of-customer survey that highlights the tool preferences of automotive aftermarket service technicians. The survey of 400 automotive technicians across the United States used a combination of computer-assisted telephone and computer-aided web interviewing methods. Respondents we...

Colloquially referred to as cell phones, mobile handsets primarily serve as portable telephones that can make and receive calls and transmit and receive data over a cellular radio link while the user is moving within a defined service area. Mobile handsets encompass smartphones, smart feature phones, and feature phones, and their chief distinctions...

Pharmaceutical drug discovery and development suffers from declining success rates with new molecules, and the rate of return has shrunk from 16% in 2011 to almost 11% in 2018. Frost & Sullivan finds that traditional solutions focused primarily on data from limited sources and rule-based computational techniques used to address the understanding of...

Nanophotonics is the science of controlling light generation, manipulation, transport, and detection on ultra-small length scales. It is an emerging technology that involves the interaction of light with structures smaller than approximately 100nm. The technology has a far-reaching application landscape, and photovoltaics and displays are likely...

25 Apr 2022  |  North America  |  Frost Radar

Frost Radar™: Artificial Intelligence-enabled Drug Discovery, 2022

A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

Infographics

×

Pharmaceutical drug discovery and development has been suffering from declining success rates with new molecules primarily because of poor external validity of preclinical models and lack of efficacy of the molecule in terms of the intended disease indication. Drug success rates continue to be in the range of only 1 in 10 that enters clinical phase...

This edition of the Cyber Security Technology Opportunity Engine (TOE) captures developments related to Zero-trust and Secure Remote Access , Asset Intelligence and Protection, Advanced Threat Protection, Cloud Security, Security Pentesting. Cyber Security TOE’s mission is to investigate new and emerging developments that aim to protect the network...

This edition of the Cyber Security Technology Opportunity Engine (TOE) captures developments related to Innovations in AI, Cloud and Network Security, Threat and Behavioural Intelligence, Risk and Vulnerability Assessment, Access Control, Blockchain Security. Cyber Security TOE’s mission is to investigate new and emerging developments that aim to p...

This edition of the Cyber Security Technology Opportunity Engine (TOE) captures developments related to Innovations in Incident Response and Detection, AI-based Cybersecurity, Zero Trust Security, Observability Platform, Vulnerability Management, Documentation Security Assessments, Quantum-safe Cryptography, Predictive Vulnerability Assessment. Cy...